BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ilett EE, Jørgensen M, Noguera-Julian M, Nørgaard JC, Daugaard G, Helleberg M, Paredes R, Murray DD, Lundgren J, MacPherson C, Reekie J, Sengeløv H. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. Blood Adv 2020;4:5797-809. [PMID: 33232475 DOI: 10.1182/bloodadvances.2020002677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Le Bastard Q, Chevallier P, Montassier E. Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease. World J Gastroenterol 2021; 27(45): 7792-7800 [PMID: 34963742 DOI: 10.3748/wjg.v27.i45.7792] [Reference Citation Analysis]
2 Kumari R, Palaniyandi S, Hildebrandt GC. The microbiome-the revealing of a long time unbeknownst factor for outcome in murine models of graft-versus-host disease. Bone Marrow Transplant 2021;56:1777-83. [PMID: 34052837 DOI: 10.1038/s41409-021-01325-7] [Reference Citation Analysis]
3 Gjærde LK, Sørensen ALT, Hjorth von Stemann J, Fischer-Nielsen A, Hansen MB, Sengeløv H, Ostrowski SR. Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther 2021:S2666-6367(21)01036-8. [PMID: 34252580 DOI: 10.1016/j.jtct.2021.07.001] [Reference Citation Analysis]
4 Grajeda-Iglesias C, Durand S, Daillère R, Iribarren K, Lemaitre F, Derosa L, Aprahamian F, Bossut N, Nirmalathasan N, Madeo F, Zitvogel L, Kroemer G. Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites. Aging (Albany NY) 2021;13:6375-405. [PMID: 33653967 DOI: 10.18632/aging.202739] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
5 Jiang H, Zhao X, Zang M, Fu R, Shao Z, Liu C, Gambini J. Gut Microbiome and Plasma Metabolomic Analysis in Patients with Myelodysplastic Syndrome. Oxidative Medicine and Cellular Longevity 2022;2022:1-21. [DOI: 10.1155/2022/1482811] [Reference Citation Analysis]
6 Lin D, Hu B, Li P, Zhao Y, Xu Y, Wu D. Roles of the intestinal microbiota and microbial metabolites in acute GVHD. Exp Hematol Oncol 2021;10:49. [PMID: 34706782 DOI: 10.1186/s40164-021-00240-3] [Reference Citation Analysis]
7 Van Lier YF, Van den Brink MRM, Hazenberg MD, Markey KA. The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets. Haematologica 2021;106:2042-53. [PMID: 33882637 DOI: 10.3324/haematol.2020.270835] [Reference Citation Analysis]
8 Castagnoli R, Pala F, Bosticardo M, Licari A, Delmonte OM, Villa A, Marseglia GL, Notarangelo LD. Gut Microbiota-Host Interactions in Inborn Errors of Immunity. Int J Mol Sci 2021;22:1416. [PMID: 33572538 DOI: 10.3390/ijms22031416] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Saqr A, Carlson B, Staley C, Rashidi A, Al-Kofahi M, Kaiser T, Holtan S, MacMillan M, Young JA, Jurdi NE, Weisdorf D, Khoruts A, Jacobson PA. Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations are Associated with the Stool Bacterial Microbiome After Hematopoietic Cell Transplantation. Transplant Cell Ther 2022:S2666-6367(22)01241-6. [PMID: 35489611 DOI: 10.1016/j.jtct.2022.04.018] [Reference Citation Analysis]
10 Kouidhi S, Souai N, Zidi O, Mosbah A, Lakhal A, Ben Othmane T, Belloumi D, Ben Ayed F, Asimakis E, Stathopoulou P, Cherif A, Tsiamis G. High Throughput Analysis Reveals Changes in Gut Microbiota and Specific Fecal Metabolomic Signature in Hematopoietic Stem Cell Transplant Patients. Microorganisms 2021;9:1845. [PMID: 34576740 DOI: 10.3390/microorganisms9091845] [Reference Citation Analysis]
11 Bansal R, Park H, Taborda CC, Gordillo C, Mapara MY, Assal A, Uhlemann AC, Reshef R. Antibiotic exposure, not alloreactivity, is the major driver of microbiome changes in hematopoietic cell transplantation: Antibiotics in auto and allo transplant. Transplant Cell Ther 2021:S2666-6367(21)01448-2. [PMID: 34958974 DOI: 10.1016/j.jtct.2021.12.015] [Reference Citation Analysis]
12 Han L, Zhang H, Ma P, Peng J, Li Y, Wu J, Li Y, Yu J, Li W, Zhang M, He JB, Fan Z, Wang W, Sang L, Sun H, Liu Q, Liu Y, Jiang Z. Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation. Ann Hematol 2022. [PMID: 35332375 DOI: 10.1007/s00277-022-04817-8] [Reference Citation Analysis]
13 Heidrich V, Bruno JS, Knebel FH, de Molla VC, Miranda-Silva W, Asprino PF, Tucunduva L, Rocha V, Novis Y, Arrais-Rodrigues C, Fregnani ER, Camargo AA. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol 2021;12:692225. [PMID: 34220852 DOI: 10.3389/fimmu.2021.692225] [Reference Citation Analysis]
14 Aggarwal N, Deerhake ME, Dipalma D, Shahi SK, Gaggioli MR, Mangalam AK, Shinohara ML. Secreted osteopontin from CD4+ T cells limits acute graft-versus-host disease. Cell Reports 2021;37:110170. [DOI: 10.1016/j.celrep.2021.110170] [Reference Citation Analysis]